SCHEMBL10131207

SCHEMBL10131207

Nc1cc(I)nc2c(I)cnn12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 8/20 0.37
CCNA2 P20248 8/20 0.37
CDK2 P24941 8/20 0.37
CCNA1 P78396 8/20 0.37
KDM4E B2RXH2 4/20 0.37
MEN1 O00255 4/20 0.37
NPC1 O15118 4/20 0.37
MAPT P10636 4/20 0.37
RAB9A P51151 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
GFER P55789 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13901469 0.75 CHEK1 (0.69) CHEK1CCNA2CDK2CCNA1KDM4E
SCHEMBL13901482 0.71 ADORA2A (0.46) CHEK1CCNA2CDK2CCNA1KDM4E
SCHEMBL16104567 0.70 CHEK1 (0.44) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL10328065 0.70 CHEK1 (0.44) CHEK1CCNA2CDK2CCNA1MAPT
SCHEMBL30579310 0.69 SMPD3 (0.35) CHEK1CCNA2CDK2CCNA1KDM4E
SCHEMBL11930831 0.69 HRH4 (0.49) TYK2
SCHEMBL16104605 0.68 CHEK1 (0.40) CHEK1CCNA2CDK2CCNA1
SCHEMBL14316241 0.65 CDK2 (0.46) CHEK1CCNA2CDK2CCNA1KDM4E
SCHEMBL29962126 0.61 PIM1 (0.49) CYP1A2CYP3A4TYK2
SCHEMBL23242923 0.61 MEN1 (0.42) CHEK1CCNA2CDK2CCNA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047569-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-04-12 WO disclosed